Dose dependent effect of resveratrol in preventing cisplatin-induced ovarian damage in rats: An experimental study.

[1]  Ferda Özkan,et al.  Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague-Dawley rats. , 2015, Reproductive biomedicine online.

[2]  O. Erbaş,et al.  Oxytocin Improves Follicular Reserve in a Cisplatin-Induced Gonadotoxicity Model in Rats , 2014, BioMed research international.

[3]  D. Keefe,et al.  Resveratrol protects against age-associated infertility in mice. , 2013, Human reproduction.

[4]  U. Turhan,et al.  Ameliorative effects of resveratrol on acute ovarian toxicity induced by total body irradiation in young adult rats. , 2012, Journal of pediatric and adolescent gynecology.

[5]  L. Luo,et al.  Resveratrol, an effective regulator of ovarian development and oocyte apoptosis , 2011, Journal of endocrinological investigation.

[6]  L. Luo,et al.  Effects of plant polyphenols on ovarian follicular reserve in aging rats. , 2010, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[7]  Ahmet Ozturk,et al.  Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist. , 2010, Fertility and sterility.

[8]  N. Raine-Fenning,et al.  A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. , 2010, Fertility and sterility.

[9]  J. Jeruss,et al.  Preservation of fertility in patients with cancer. , 2009, The New England journal of medicine.

[10]  G. Mithieux,et al.  Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. , 2008, European journal of pharmacology.

[11]  J. Donnez,et al.  Laparoscopic ovariectomy for whole human ovary cryopreservation: technical aspects. , 2007, Fertility and sterility.

[12]  F. López‐Soriano,et al.  Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. , 2007, Cancer letters.

[13]  A. Gadducci,et al.  Ovarian function and childbearing issues in breast cancer survivors , 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[14]  Jennifer L. Peresie,et al.  Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage. , 2006, Biochemical and biophysical research communications.

[15]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[16]  Hong Zhu,et al.  Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. , 2006, Pharmacological research.

[17]  P. Serhal,et al.  Antral follicle count, anti‐mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? , 2005, BJOG : an international journal of obstetrics and gynaecology.

[18]  L. Barenghi,et al.  Cardiovascular protective effects of resveratrol. , 2006, Cardiovascular drug reviews.

[19]  S. I. Kseneva,et al.  Morphological and Functional State of Rat Ovaries in Early and Late Periods after Administration of Platinum Cytostatics , 2004, Bulletin of Experimental Biology and Medicine.

[20]  Hsin-Yi Huang,et al.  Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats , 2004, Clinical Cancer Research.

[21]  M. C. Terek,et al.  Effect of chemotherapy on primordial follicular reserve of rat: An animal model of premature ovarian failure and infertility , 2004, The Australian & New Zealand journal of obstetrics & gynaecology.

[22]  J. Visser,et al.  Anti-Müllerian hormone and its role in ovarian function , 2003, Molecular and Cellular Endocrinology.

[23]  R. Fanchin,et al.  Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. , 2003, Human reproduction.

[24]  D. Meirow Reproduction post-chemotherapy in young cancer patients , 2000, Molecular and Cellular Endocrinology.

[25]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[26]  E. Diamandis,et al.  Wine as a biological fluid: History, production, and role in disease prevention , 1997, Journal of clinical laboratory analysis.

[27]  J. Schornagel,et al.  The formation and persistence of carboplatin-DNA adducts in rats , 1996, Cancer Chemotherapy and Pharmacology.

[28]  G. Scambia,et al.  Menstrual and hormone patterns in women treated with high-dose cisplatin and bleomycin. , 1994, Gynecologic oncology.

[29]  P. Donahoe,et al.  Mullerian inhibiting substance: a gonadal hormone with multiple functions. , 1993, Endocrine reviews.

[30]  J. Waxman,et al.  Chemotherapy and the Adult Gonad: A Review 1 , 1983, Journal of the Royal Society of Medicine.